The Assistance Publique - Hôpitaux de Paris in conducting a study looking at the benefits of using IgIV in combination with prednisone compared to using dexamethasone as a stand-alone treatment for adults with ITP, in any disease phase (newly diagnosed, persistent, or chronic). Adults between the ages of 18-80 years with a confirmed diagnosis of ITP, a platelet count less than 20,000 µL, and a history of any type of bleeding (skin or mucosal bleeding) are eligible to participant.
France
Recruiting